MEV-IONOSPHERE

Proton Therapy News, Insights and Education.

Mevion Industry Symposium:Application of MLC-based IMPT in Complex Clinical Cases

In IMPT-based proton therapy, spot size and lateral penumbra are critical to precisely deliver treatment and spare critical structures close to the target. Using Mevion’s HYPERSCAN PBS with Adaptive Aperture proton MLC, an optimal spot size and sharper penumbra can be achieved at each energy layer of the target, thus creating a more conformal treatment field than previously achievable by relying on small spot sizes alone.

In July, users who have successfully deployed Mevion’s Adaptive Aperture proton MLC in their clinical programs presented at Mevion Industry Symposium at NAPT 2020. The speakers shared the advantages they have experienced and how MLC-enhanced IMPT may further advance the treatment paradigm of proton therapy over IMRT through improved proton dose conformality.

Watch the symposium recordings here:

Introduction: MLC Based IMPT In Complex Cases

 

Skip Rosenthal, PhD

Senior VP, Clinical Relationships

Mevion Medical Systems

 

 

 

Comparative Effectiveness of Proton vs. Photon and the Promise of IMPT
Brian Baumann, MD

Assistant Professor, Radiation Oncology

Chief, Genitourinary Service

Washington University in St. Louis 

 

 

Dosimetric Effect of Implanted Markers in Pencil Beam Scanning Proton Beam Therapy for Accelerated Partial Breast Irradiation

Hosang Jin, PhD

Associate Professor

Department of Radiation Oncology

The University of Oklahoma

 

 

First Clinical Experience with HYPERSCAN Pencil Beam Scanning

Brian Collins, MD

Medical Director

Department of Radiation Medicine 

MedStar Georgetown University Hospital 

 

 

Get our blog delivered to your inbox. Subscribe here.

IGPT